Llwytho...
CA2-05: Continuous Monitoring and Timely Intervention are Needed to Improve Adherence to Adjuvant Hormonal Therapy Among Breast Cancer Patients
BACKGROUND/AIMS: There are approximately 150,000 new hormone-sensitive breast cancer cases in the U.S. each year. Numerous studies have shown that adjuvant hormonal therapy (AHT) dramatically reduces breast cancer recurrence and mortality. Daily treatment for 5 years is the recommended therapy among...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Marshfield Clinic
2012
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3421386/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2012.1100.ca2-05 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|